ArticleJournal of gastrointestinal oncology2017

A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients.

Ramesh K Ramanathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.